Back

Cardiac resynchronization therapy in patients with a history of atrial fibrillation: insights from five major clinical trials

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: CRT news Device Treatment EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Frederik Dalgaard

Gentofte University Hospital, Gentofte (Denmark)

4 More presentations in this session

Presentation thumbnail
Impact of the ESC 2021 guidelines on cardiac pacing and cardiac resynchronization therapy left bundle branch block definition on CRT patient selection and survival
Mr J. Rijks (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Explainable deep learning outperforms guideline criteria and QRSarea for prediction of outcome after cardiac resynchronization therapy
Mr P. Wouters (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Direct comparison of delivery systems and electrodes with and without stylets for stimulation of the left bundle branch area in patients with indications for cardioresynchronization therapy
Professor I. Karpenko (Odessa, UA)
Abstract
Presentation thumbnail
Apical versus septal pacing - can we chose the localization of ventricular lead in order to prevent upgrade to cardiac resynchronization therapy?
Doctor P. Silverio Antonio (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
CRT news

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources